Loading...
XJPX
3088
Market cap7.25bUSD
Dec 05, Last price  
2,832.00JPY
1D
-0.16%
1Q
-10.86%
Jan 2017
-1.67%
IPO
155.14%
Name

MatsukiyoCocokara & Co

Chart & Performance

D1W1MN
XJPX:3088 chart
P/E
20.61
P/S
1.06
EPS
137.40
Div Yield, %
1.45%
Shrs. gr., 5y
-0.41%
Rev. gr., 5y
12.44%
Revenues
1.06t
+3.82%
312,982,000,000345,460,000,000390,934,000,000392,268,000,000393,007,000,000428,184,000,000434,597,000,000456,311,000,000495,385,000,000485,512,000,000536,052,000,000535,133,000,000558,879,000,000575,991,000,000590,593,000,000556,907,000,000729,969,000,000951,247,000,0001,022,531,000,0001,061,626,000,000
Net income
54.68b
+4.45%
2,309,000,0004,133,000,0006,801,000,0007,728,000,0007,281,000,0007,291,000,0009,955,000,00011,270,000,00013,355,000,00011,619,000,00017,853,000,00020,119,000,00022,755,000,00025,035,000,00026,176,000,00021,602,000,00034,377,000,00040,545,000,00052,347,000,00054,675,000,000
CFO
81.47b
+28.29%
5,758,000,00016,964,000,00018,313,000,0009,423,000,0007,555,000,00011,266,000,00016,246,000,00019,175,000,00026,216,000,0009,010,000,00031,075,000,00023,722,000,00027,938,000,00021,897,000,00024,764,000,00025,875,000,00039,812,000,00064,061,000,00063,506,000,00081,472,000,000
Dividend
Mar 30, 202624 JPY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

MatsukiyoCocokara & Co. operates a chain of drug stores and pharmacies in Japan. As of June 30, 2020, it operated through a network of 1,726 stores in 47 prefectures in Japan. MatsukiyoCocokara & Co. was founded in 1932 and is based in Matsudo, Japan.
IPO date
Oct 01, 2007
Employees
13,657
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑032024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑032016‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT